WO2002044368A1 - Nouvelles proteines du recepteur couple a la proteine g et leurs adn - Google Patents

Nouvelles proteines du recepteur couple a la proteine g et leurs adn Download PDF

Info

Publication number
WO2002044368A1
WO2002044368A1 PCT/JP2001/010418 JP0110418W WO0244368A1 WO 2002044368 A1 WO2002044368 A1 WO 2002044368A1 JP 0110418 W JP0110418 W JP 0110418W WO 0244368 A1 WO0244368 A1 WO 0244368A1
Authority
WO
WIPO (PCT)
Prior art keywords
proteins
screening
ligand
dnas
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2001/010418
Other languages
English (en)
French (fr)
Inventor
Yasuko Terao
Yasushi Shintani
Mioko Harada
Yukio Shimomura
Masaaki Mori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Priority to AU2002218495A priority Critical patent/AU2002218495A1/en
Priority to EP01998185A priority patent/EP1344823A4/en
Priority to US10/433,561 priority patent/US20040029178A1/en
Publication of WO2002044368A1 publication Critical patent/WO2002044368A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PCT/JP2001/010418 2000-11-30 2001-11-29 Nouvelles proteines du recepteur couple a la proteine g et leurs adn Ceased WO2002044368A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2002218495A AU2002218495A1 (en) 2000-11-30 2001-11-29 Novel g protein-coupled receptor proteins and dnas thereof
EP01998185A EP1344823A4 (en) 2000-11-30 2001-11-29 NEW G-PROTEIN-COUPLED RECEPTOR PROTEINS AND THEIR DNAS
US10/433,561 US20040029178A1 (en) 2000-11-30 2001-11-29 Novel g protein-coupled receptor proteins and dnas thereof

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
JP2000364801 2000-11-30
JP2000-364801 2000-11-30
JP2001-87482 2001-03-26
JP2001087482 2001-03-26
JP2001-145434 2001-05-15
JP2001145434 2001-05-15
JP2001-270838 2001-09-06
JP2001270838 2001-09-06

Publications (1)

Publication Number Publication Date
WO2002044368A1 true WO2002044368A1 (fr) 2002-06-06

Family

ID=27481833

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2001/010418 Ceased WO2002044368A1 (fr) 2000-11-30 2001-11-29 Nouvelles proteines du recepteur couple a la proteine g et leurs adn

Country Status (4)

Country Link
US (1) US20040029178A1 (ja)
EP (1) EP1344823A4 (ja)
AU (1) AU2002218495A1 (ja)
WO (1) WO2002044368A1 (ja)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002102847A1 (fr) * 2001-06-14 2002-12-27 Takeda Chemical Industries, Ltd. Nouveau ligand et son adn
WO2003045994A1 (fr) * 2001-11-26 2003-06-05 Takeda Chemical Industries, Ltd. Nouveau ligand et adn de ce ligand
WO2003082907A1 (en) * 2002-03-29 2003-10-09 Euroscreen Sa Ligands for g protein coupled receptor gpr7 and uses thereof
WO2004041301A1 (ja) * 2002-11-06 2004-05-21 Takeda Pharmaceutical Company Limited 抗利尿剤
EP1293567A4 (en) * 2000-06-21 2005-02-16 Takeda Pharmaceutical GPR8 LIGAND AND DAFUER ENCODING DNA (02.01.02)
US7247440B2 (en) 2001-05-15 2007-07-24 Takeda Pharmaceutical Company Limited Method of screening preventives or remedies for obesity

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003057236A1 (fr) * 2001-12-28 2003-07-17 Takeda Chemical Industries, Ltd. Inhibiteur de prise de poids corporel

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995012670A1 (en) * 1993-11-05 1995-05-11 Alcoholism And Drug Addiction Research Foundation Opioid receptor: compositions and methods
JPH09121865A (ja) * 1995-10-30 1997-05-13 Takeda Chem Ind Ltd 新規ｇ蛋白質共役型レセプター蛋白質、その製造法および用途
WO2000022129A1 (en) * 1998-10-13 2000-04-20 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human g protein-coupled receptors

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995012670A1 (en) * 1993-11-05 1995-05-11 Alcoholism And Drug Addiction Research Foundation Opioid receptor: compositions and methods
JPH09121865A (ja) * 1995-10-30 1997-05-13 Takeda Chem Ind Ltd 新規ｇ蛋白質共役型レセプター蛋白質、その製造法および用途
WO2000022129A1 (en) * 1998-10-13 2000-04-20 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human g protein-coupled receptors

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
LIBERT, F. ET AL.: "Selective amplification and cloning of four new members of the G protein-coupled receptor family", SCIENCE, vol. 244, no. 4904, 1989, pages 569 - 572, XP000073306 *
O'DOWD, B.F. ET AL.: "The cloning and chromosomal mapping of two novel human opioid-somatostatin-like receptor genes, GPR7 and GPR8, expressed in discrete areas of the brain", GENOMICS, vol. 28, no. 1, 1995, pages 84 - 91, XP002908807 *
See also references of EP1344823A4 *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1293567A4 (en) * 2000-06-21 2005-02-16 Takeda Pharmaceutical GPR8 LIGAND AND DAFUER ENCODING DNA (02.01.02)
US7193033B2 (en) 2000-06-21 2007-03-20 Takeda Pharmaceutical Company Limited Peptide having appetite stimulating activity
US7671174B2 (en) 2000-06-21 2010-03-02 Takeda Pharmaceutical Company Limited Ligand to GPR8
US7247440B2 (en) 2001-05-15 2007-07-24 Takeda Pharmaceutical Company Limited Method of screening preventives or remedies for obesity
WO2002102847A1 (fr) * 2001-06-14 2002-12-27 Takeda Chemical Industries, Ltd. Nouveau ligand et son adn
US7268212B2 (en) 2001-06-14 2007-09-11 Takeda Pharmaceutical Company Limited Ligand of G protein-coupled receptor protein and DNA thereof
WO2003045994A1 (fr) * 2001-11-26 2003-06-05 Takeda Chemical Industries, Ltd. Nouveau ligand et adn de ce ligand
WO2003082907A1 (en) * 2002-03-29 2003-10-09 Euroscreen Sa Ligands for g protein coupled receptor gpr7 and uses thereof
WO2004041301A1 (ja) * 2002-11-06 2004-05-21 Takeda Pharmaceutical Company Limited 抗利尿剤

Also Published As

Publication number Publication date
AU2002218495A1 (en) 2002-06-11
EP1344823A1 (en) 2003-09-17
EP1344823A4 (en) 2005-03-16
US20040029178A1 (en) 2004-02-12

Similar Documents

Publication Publication Date Title
WO2002084286A1 (en) Screening method
WO2001077172A3 (en) Non-endogenous, constitutively activated known g protein-coupled receptors
WO2003093269A3 (de) Substituierte pyrazolo-pyrimidin-4-one
WO2004082623A3 (en) Substituted piperidine compounds
WO1999048523A3 (en) Antagonists of the inflammatory mediator oncostatin m (osm)
AU2003237508A1 (en) Determining fluid composition from fluid properties
WO2002044368A1 (fr) Nouvelles proteines du recepteur couple a la proteine g et leurs adn
WO2005033066A3 (fr) Derives d'arylalkylcarbamates, leur preparation et leur application en therapeutique sanofi-synthelabo
WO2002064092A3 (en) Method for evaluating therapeutic efficacy
CA2414641A1 (en) Whey protein retarder
AU2003242106A1 (en) Detection kit, assay plate to be used therein, detection method, evaluation method, polyclonal antibody of frog vitellogenin and procss for producing the same
WO2002004624A9 (fr) Nouvelle proteine receptrice couplee a la proteine g et adn destine a celle-ci
WO2002060948A1 (fr) Nouvelle proteine recepteur couplee a une proteine g et adn correspondant
WO2002061075A1 (fr) Proteine de recepteur couple aux proteines g et adn correspondant
WO2003012104A1 (en) Novel g protein-coupled receptor protein and dna thereof
WO2003021262A1 (fr) Procede de criblage
IL150824A0 (en) Screening method
WO2002086505A3 (en) Intracellular analysis
WO2003008445A1 (fr) Nouvelle proteine receptrice couplee a la proteine g, et adn codant pour elle
WO2002061083A1 (fr) Nouvelle proteine de recepteur couple aux proteines g et son adn
BRPI0410252A (pt) materiais de revestimento de um componente termicamente curáveis, sua preparação e uso
WO2003025179A1 (fr) Nouveau polypeptide, adn associe et utilisation de ce polypeptide
CA2385766A1 (en) Methods for production of proteins in host cells
WO2003005036A3 (en) Epf receptor assays, compounds and therapeutic compositions
DE602004030899D1 (de) Neues screening-verfahren

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 10433561

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2001998185

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001998185

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2001998185

Country of ref document: EP